# Applied Industrial Technologies Inc: Form 10-Q for the period ended Dec 31, 2024

- Company: [Applied Industrial Technologies Inc](/companies/ait.md) (CIK 109563)
- Form: 10-Q
- Filed: 2025-01-29
- Accepted by EDGAR: Jan 29, 2025, 16:09 ET
- Period: 2024-12-31
- Accession: 0000109563-25-000026
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/109563/000010956325000026/ait-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/109563/000010956325000026/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-10-01 to 2024-12-31 | $1.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2024-07-01 to 2024-12-31 | $2.17bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2024-10-01 to 2024-12-31 | $745.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2024-07-01 to 2024-12-31 | $1.52bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-10-01 to 2024-12-31 | $328.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2024-07-01 to 2024-12-31 | $653.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2024-10-01 to 2024-12-31 | $207.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2024-07-01 to 2024-12-31 | $419.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-10-01 to 2024-12-31 | $120.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2024-07-01 to 2024-12-31 | $234.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2024-10-01 to 2024-12-31 | $29.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2024-07-01 to 2024-12-31 | $53.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-10-01 to 2024-12-31 | $93.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-07-01 to 2024-12-31 | $185.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-10-01 to 2024-12-31 | $2.39 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-07-01 to 2024-12-31 | $4.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-10-01 to 2024-12-31 | $2.43 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-07-01 to 2024-12-31 | $4.83 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-10-01 to 2024-12-31 | 38,963,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-07-01 to 2024-12-31 | 38,956,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-07-01 to 2024-12-31 | $222.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-10-01 to 2024-12-31 | $5.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 6 months, 2024-07-01 to 2024-12-31 | $10.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months, 2024-07-01 to 2024-12-31 | $28.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2024-07-01 to 2024-12-31 | $30.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2024-12-31 | $1.61bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $3.04bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $429.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $1.25bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $572.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2024-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2024-12-31 | $1.79bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,067 characters.

Repurchases of common stock in the quarter ended December 31, 2024 were as follows:

| Period | (a) Total Number of Shares | (b) Average Price Paid per Share ($) | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1) |
| --- | ---: | ---: | ---: | ---: |
| October 1, 2024 to October 31, 2024 | 0 | $0.00 | 0 | 1,050,000 |
| November 1, 2024 to November 30, 2024 | 0 | $0.00 | 0 | 1,050,000 |
| December 1, 2024 to December 31, 2024 | 75,376 | $265.35 | 75,376 | 974,624 |
| Total | 75,376 | $265.35 | 75,376 | 974,624 |

(1) On August 9, 2022, the Board of Directors authorized the repurchase of up to 1.5 million shares of the Company's common stock, replacing the prior authorization. We publicly announced the new authorization on August 11, 2022. Purchases can be made in the open market or in privately negotiated transactions. The authorization is in effect until all shares are purchased, or the Board revokes or amends the authorization.

## Market risk

As filed, 204 characters.

For quantitative and qualitative disclosures about market risk, see Item 7A "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended June 30, 2024.

## Controls and procedures

As filed, 1,447 characters.

#### Evaluation of Disclosure Controls and Procedures

The Company's management, under the supervision and with the participation of the Chief Executive Officer (CEO) and Chief Financial Officer (CFO), evaluated the effectiveness of the Company's disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, the CEO and CFO concluded that the Company's disclosure controls and procedures are effective.

#### Changes in Internal Control Over Financial Reporting

On December 31, 2024, the Company completed the acquisition of Hydradyne, LLC (Hydradyne). As permitted by SEC guidance, the scope of management’s evaluation of internal control over financing reporting as of December 31, 2024 did not include the internal control over financial reporting of Hydradyne. Management is in the process of integrating, evaluating, and where necessary, implementing changes in controls and procedures in Hydradyne. As a result, the Company anticipates excluding Hydradyne from our evaluation of internal control over financial reporting as of June 30, 2025.

Other than with respect to the acquisition of Hydradyne, there are no changes in internal control over financial reporting during the three months ended December 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Filed Jan 29, 2025.
Source: SEC EDGAR, the filing index for accession 0000109563-25-000026. Last ingested by Listed: Oct 27, 2026, 21:29 ET. No prices; not investment advice.
